The public health control of scabies: priorities for research and action

Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged populations. The disease causes considerable morbidity and leads to severe bacterial infection and immune-mediated disease. Scientific advances from the past 5 years suggest that scabies is amenable to populatio...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 394; no. 10192; pp. 81 - 92
Main Authors Engelman, Daniel, Cantey, Paul T, Marks, Michael, Solomon, Anthony W, Chang, Aileen Y, Chosidow, Olivier, Enbiale, Wendemagegn, Engels, Dirk, Hay, Roderick J, Hendrickx, David, Hotez, Peter J, Kaldor, John M, Kama, Mike, Mackenzie, Charles D, McCarthy, James S, Martin, Diana L, Mengistu, Birhan, Maurer, Toby, Negussu, Nebiyu, Romani, Lucia, Sokana, Oliver, Whitfeld, Margot J, Fuller, L Claire, Steer, Andrew C
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 06.07.2019
Elsevier Limited
Subjects
Children
Disease
Displaced persons
Donations
Epidemics
Global Health
Humans
Infections
Ivermectin
Low income groups
Mapping
Mass Drug Administration
Medical treatment
Microscopy
Morbidity
Neglected Diseases - prevention & control
Operations research
Parasitic diseases
Population
Population Surveillance
Public Health
Scabies
Scabies - prevention & control
Skin diseases
Tropical diseases
World Health Organization
Australia
Online AccessGet full text

Cover

More Information
Summary:Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged populations. The disease causes considerable morbidity and leads to severe bacterial infection and immune-mediated disease. Scientific advances from the past 5 years suggest that scabies is amenable to population-level control, particularly through mass drug administration. In recognition of these issues, WHO added scabies to the list of neglected tropical diseases in 2017. To develop a global control programme, key operational research questions must now be addressed. Standardised approaches to diagnosis and methods for mapping are required to further understand the burden of disease. The safety of treatments for young children, including with ivermectin and moxidectin, should be investigated. Studies are needed to inform optimum implementation of mass treatment, including the threshold for intervention, target, dosing, and frequency. Frameworks for surveillance, monitoring, and evaluation of control strategies are also necessary.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Contributors
DaE and ACS conceived the project. DaE searched and reviewed the literature, wrote the first draft of the manuscript, made revisions, and prepared figure 3. DaE, LR, MJW, JMK, and ACS reviewed prevalence data for figure 2. DaE, PTC, MM, AWS, JMK, and ACS contributed to further development of the structure and content. All authors reviewed drafts of the manuscript, provided comments and critical review, helped to revise the manuscript, and agreed to the final version.
ISSN:0140-6736
1474-547X
1474-547X
DOI:10.1016/S0140-6736(19)31136-5